Related Experiment Video
Updated: Jul 28, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Screening programmes for tuberculosis in new entrants across Europe.
1Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom. richard.coker@lshtm.ac.uk
European countries show varied approaches to tuberculosis screening for new entrants. Many nations lack specific programs, and those with them use chest X-rays inconsistently, primarily for refugees.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Immigration Health
Background:
- Tuberculosis (TB) screening for foreign-born individuals is crucial for early treatment and preventing disease spread.
- New entrant screening policies in Europe were examined to understand current practices.
Purpose of the Study:
- To survey and analyze tuberculosis (TB) screening programs for new entrants across European countries.
- To identify the prevalence and characteristics of TB screening initiatives in Europe.
Main Methods:
- A survey was conducted in January 2003 targeting new entrant screening programs in Europe.
- Responses were collected from 26 countries regarding their TB screening strategies.
Main Results:
- 50% of surveyed European countries (13 out of 26) had no specific TB screening programs for new entrants.
- Of the 13 countries with programs, screening occurred at ports of entry or other centers, not pre-entry.
- Chest X-rays were universally used, but clinical approaches varied significantly among the programs, primarily targeting refugees.
Conclusions:
- Significant heterogeneity exists in European TB screening programs for new entrants.
- The lack of standardized pre-entry screening and varied methodologies may impact the effectiveness of TB control in mobile populations.
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

